These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5852705)

  • 1. Prevention of traumatic bleeding by ellagic acid in rats.
    Cliffton EE; Agostino D; Girolami A
    Proc Soc Exp Biol Med; 1965 Oct; 120(1):179-80. PubMed ID: 5852705
    [No Abstract]   [Full Text] [Related]  

  • 2. [Activation mechanism of bovine factor XII on foreign surfaces--activation by polysaccharide sulfate and sulfatide and inhibition by platelet components].
    Kato H; Shimada T; Ohno Y; Sugo T; Kodama K
    Rinsho Byori; 1982 Jun; Suppl 50():102-13. PubMed ID: 6215509
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of Hageman factor by ellagic acid and the generalized Shwartzman reaction.
    McKay DG; Müller-Berghaus G; Cruse V
    Am J Pathol; 1969 Mar; 54(3):393-420. PubMed ID: 4975375
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of ellagic acid on coagulation in vivo.
    Girolami A; Agostino D; Cliffton EE
    Blood; 1966 Jan; 27(1):93-102. PubMed ID: 5902867
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of ellagic acid on the coagulation mechanisms and on traumatic bleeding.
    Cliffton EE
    Am J Med Sci; 1967 Oct; 254(4):483-90. PubMed ID: 6052843
    [No Abstract]   [Full Text] [Related]  

  • 6. Some cardiovascular and hematological changes induced in the rat by activation of Hageman factor with ellagic acid.
    Damas J; Remacle-Volon G; Adam A
    Adv Exp Med Biol; 1989; 247A():461-5. PubMed ID: 2603812
    [No Abstract]   [Full Text] [Related]  

  • 7. Coagulation factor concentrates and point-of-care coagulation monitoring: both might be essential for optimal treatment of trauma-induced coagulopathy.
    Grottke O; Rossaint R
    Lancet Haematol; 2017 Jun; 4(6):e246-e247. PubMed ID: 28457981
    [No Abstract]   [Full Text] [Related]  

  • 8. Reversal of dabigatran-induced bleeding by coagulation factor concentrates in a rat-tail bleeding model and lack of effect on assays of coagulation.
    van Ryn J; Schurer J; Kink-Eiband M; Clemens A
    Anesthesiology; 2014 Jun; 120(6):1429-40. PubMed ID: 24714118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contact phase of blood coagulation].
    Popova LG
    Usp Fiziol Nauk; 1980; 11(1):47-72. PubMed ID: 6989129
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation is more affected by quick than slow bleeding in patients with massive blood loss.
    Zhao J; Yang D; Zheng D
    Blood Coagul Fibrinolysis; 2017 Mar; 28(2):121-125. PubMed ID: 27007403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin complex concentrates in trauma and perioperative bleeding.
    Grottke O; Levy JH
    Anesthesiology; 2015 Apr; 122(4):923-31. PubMed ID: 25654437
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of hemolysates on the coagulation of rabbit plasma].
    Lambert PH
    C R Seances Soc Biol Fil; 1966; 160(1):202-4. PubMed ID: 4222920
    [No Abstract]   [Full Text] [Related]  

  • 13. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
    Ratnoff OD; Saito H
    J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombogenicity of a new prothrombin complex concentrate].
    Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure of tranexamic acid to influence the ellagic acid-induced hypercoagulable state.
    Girolami A; Cella G; Burul A; Zucchetto M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(2):261-70. PubMed ID: 61921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Flavellagic acid influence on blood coagulation and hemostasis disturbed by whole body irradiation].
    Pospísil J; Skala E; Zitko M; Dienstbier Z
    Strahlentherapie; 1983 May; 159(5):299-305. PubMed ID: 6344348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of activated prothrombin complex concentrate as potential hirudin antidote in animal models.
    Diehl KH; Römisch J; Hein B; Jessel A; Ronneberger H; Pâques EP
    Haemostasis; 1995; 25(4):182-92. PubMed ID: 7557657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombogenicity of antihemophiliac preparations with factor VIII inhibitor bypassing activity.
    Melewski DJ; Huebschmann J; Tourbaf K; Ambrus CM; Ambrus JL
    J Med; 1981; 12(2-3):89-96. PubMed ID: 6974212
    [No Abstract]   [Full Text] [Related]  

  • 19. [Action of ellagic acid on the time and intensity of hemorrhage in irradiated rats].
    Pasotti C; Marchesani F; Coppi M
    Minerva Med; 1969 Dec; 60(98):4954-8. PubMed ID: 5357561
    [No Abstract]   [Full Text] [Related]  

  • 20. Interference with fibrin stabilization by polymyxin B sulfate.
    Marshall FN; Massad EN
    Proc Soc Exp Biol Med; 1967 Jun; 125(2):420-3. PubMed ID: 4291164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.